Larry Robbins's TEVA Position Overview
Larry Robbins (via Glenview Capital Management, LLC) currently holds 6.66 M shares of Teva Pharmaceutical Industries Limited (TEVA) worth $200.61 M, representing 5.04% of the portfolio. First purchased in 2015-Q2, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Larry Robbins has maintained a strategic position in TEVA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 6.32 M shares. Largest reduction occurred in Q1 2026, reducing 10.06 M shares.
Analysis based on 13F filings available since 2013 Q2
Larry Robbins's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Larry Robbins
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -10.06 M | Reduce 60.17% | 6.66 M | $30.12 |
| Q4 2025 | +27,529 | Add 0.16% | 16.72 M | $31.21 |
| Q3 2025 | +868,457 | Add 5.49% | 16.69 M | $20.20 |
| Q2 2025 | +1.05 M | Add 7.07% | 15.82 M | $16.76 |
| Q1 2025 | +6.32 M | Add 74.76% | 14.78 M | $15.37 |
| Q3 2024 | -701,317 | Reduce 7.66% | 8.46 M | $18.02 |
| Q2 2024 | +1.66 M | Add 22.08% | 9.16 M | $16.25 |
| Q1 2024 | +5.9 M | Add 367.48% | 7.5 M | $14.11 |
| Q4 2023 | +1.6 M | New Buy | 1.6 M | $10.44 |
| Q4 2016 | -2.18 M | Sold Out | 0 | $0.00 |
| Q3 2016 | -906,703 | Reduce 29.41% | 2.18 M | $46.01 |
| Q2 2016 | -2.5 M | Reduce 44.75% | 3.08 M | $50.23 |
| Q1 2016 | -376,484 | Reduce 6.32% | 5.58 M | $53.51 |
| Q4 2015 | +1.77 M | Add 42.18% | 5.96 M | $65.64 |
| Q3 2015 | +1.34 M | Add 47.26% | 4.19 M | $56.46 |
| Q2 2015 | +2.84 M | New Buy | 2.84 M | $59.10 |
Larry Robbins's Teva Pharmaceutical Industries Limited Investment FAQs
Larry Robbins first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q2 2015, acquiring 2,844,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins has held Teva Pharmaceutical Industries Limited (TEVA) for 17 quarters since Q2 2015.
Larry Robbins's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q1 2025, adding 14,778,641 shares worth $227.15 M.
According to the latest 13F filing for Q1 2026, Larry Robbins's firm, Glenview Capital Management, LLC, owns 6,660,220 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $200.61 M.
As of the Q1 2026 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 5.04% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.
Larry Robbins's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 16,720,209 shares, as reported at the end of Q4 2025.